Fang, W-H, Kumar, S, McDowell, G, Smith, D, Krupinski, J, Olah, P, Al-Baradie, RS, Al-Rukban, MO, Petcu, EB and Slevin, M (2016) Mesenchymal Stem Cells Loaded with p5, Derived from CDK5 Activator p35, Inhibit Calcium-Induced CDK5 Activation in Endothelial Cells. Stem Cells Int, 2016. ISSN 1687-966X

Preview

Text Mesenchymal Stem Cells Loaded with p5, Derived from CDK5 Activator p35, Inhibit Calcium-Induced CDK5 Activation in Endotheli.pdf - Published Version Available under License Creative Commons Attribution. Download (2MB) | Preview

Abstract

The potential use of stem cells as therapeutics in disease has gained momentum over the last few years and recently phase-I clinical trials have shown favourable results in treatment of a small cohort of acute stroke patients. Similarly, they have been used in preclinical models drug-loaded for the effective treatment of solid tumours. Here we have characterized uptake and release of a novel p5-cyclin-dependent kinase 5 (CDK5) inhibitory peptide by mesenchymal stem cells and showed release levels capable of blocking aberrant cyclin-dependent kinase 5 (CDK5) signaling pathways, through phosphorylation of cyclin-dependent kinase 5 (CDK5) and p53. These pathways represent the major acute mechanism stimulating apoptosis after stroke and hence its modulation could benefit patient recovery. This work indicates a potential use for drug-loaded stem cells as delivery vehicles for stroke therapeutics and in addition as anticancer receptacles particularly, if a targeting and/or holding mechanism can be defined.

Item Type:	Article
Subjects:	R Medicine > RM Therapeutics. Pharmacology R Medicine > RS Pharmacy and materia medica
Divisions:	Pharmacy & Biomolecular Sciences
Publisher:	Hindawi
Related URLs:	Author
Date Deposited:	06 Apr 2020 10:43
Last Modified:	04 Sep 2021 07:31
DOI or ID number:	10.1155/2016/2165462
URI:	https://researchonline.ljmu.ac.uk/id/eprint/12661

View Item